Bell Potter analyst John Hester upgraded Nanosonics Limited (NNCSF – Research Report) to a Hold yesterday and set a price target of A$3.85. The company’s shares closed last Thursday at $2.42.
According to TipRanks, Hester is a 3-star analyst with an average return of 2.0% and a 57.89% success rate. Hester covers the Healthcare sector, focusing on stocks such as Nanosonics Limited, Telix Pharmaceuticals Ltd., and Mesoblast Limited.
The word on The Street in general, suggests a Hold analyst consensus rating for Nanosonics Limited with a $2.64 average price target.
See the top stocks recommended by analysts >>
Based on Nanosonics Limited’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $0. In comparison, last year the company had a net profit of $0
Based on the recent corporate insider activity of 6 insiders, corporate insider sentiment is neutral on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Nanosonics Ltd is an Australia based healthcare equipment manufacturing company. It manufactures and distributes the trophon EPR ultrasound probe disinfector, which reduces the risk of ultrasound-related cross-infection. It also manufactures the associated consumables and accessories such as the trophon wall mount, trophon printer, trophon cart, trophon curved probe positioner and others. In addition, the company manufactures and commercializes infection control and decontamination products and services and related technologies. The entity operates in Australia and other countries, of which key revenue is derived from North America.
